Suppr超能文献

接受神经介导性晕厥治疗的患者在慢性β受体阻滞剂治疗期间头直立倾斜试验反应恶化。

Worsening of head-up tilt test response during chronic beta-blocker therapy in patients treated for neurally mediated syncope.

作者信息

Gardini A, Benedini G, Proto C

机构信息

Department of Medicine and Cardiology, Clinica S. Anna, Brescia.

出版信息

G Ital Cardiol. 1998 Aug;28(8):899-903.

PMID:9773316
Abstract

The prognosis of patients with neurally mediated syncope and asystolic response at tilt test is controversial and there is no consensus regarding their management. Many patients seem to benefit from beta-blockers and their effectiveness has been assessed with repeated tilt tests in asystolic patients as well. However, little is known about the long-term effects of beta-blockers. Preliminary data and isolated reports suggest that in some cases, these agents may actually worsen the clinical outcome or the tilt test response. Three patients are described who experienced worsening of tilt test response with prolonged asystole (19.9, 9 and 5.5 sec respectively) during chronic treatment with beta-blockers in the absence of spontaneous symptoms. At discharge, one patient received a dual-chamber pace-maker combined with metoprolol, another one continued to take metoprolol and enalapril. The third patient refused any further medication. During follow-up (8, 11, 13 months respectively), they were symptom-free. The clinical and prognostic significance of this response is not clear and needs further investigation.

摘要

神经介导性晕厥患者在直立倾斜试验中出现心脏停搏反应的预后存在争议,对于其治疗方法也没有达成共识。许多患者似乎从β受体阻滞剂中获益,并且其有效性也已在心脏停搏患者中通过重复直立倾斜试验进行了评估。然而,关于β受体阻滞剂的长期影响知之甚少。初步数据和个别报告表明,在某些情况下,这些药物实际上可能会使临床结局或直立倾斜试验反应恶化。本文描述了3例患者,他们在长期接受β受体阻滞剂治疗且无自发症状的情况下,直立倾斜试验反应恶化,出现了延长的心脏停搏(分别为19.9秒、9秒和5.5秒)。出院时,1例患者接受了双腔起搏器联合美托洛尔治疗,另1例继续服用美托洛尔和依那普利。第3例患者拒绝进一步用药。在随访期间(分别为8个月、11个月和13个月),他们均无症状。这种反应的临床和预后意义尚不清楚,需要进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验